MRAI
Marpai, Inc.
Latest Form 4:Purchase$682byJohnson Steve Andrew (Chief Financial Officer) · filed Jun 2, 2026
Marpai, Inc. (MRAI) has 13 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 2, 2026.
- Industry:Medical - Healthcare Plans
- CEO:Damien Francis Lamendola
- Employees:107
- HQ:New York City, NY, US
- IPO:2021-10-27
Insider Buying
$203K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$58.9M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Johnson Steve AndrewFirst filing | Chief Financial Officer | Purchase | 1,100 | $682 | Jun 2 | SEC ↗ |
EITAN YARONFirst in 6 months | Director | Purchase | 10,000 | $3K | May 22 | SEC ↗ |
EITAN YARONFirst filing | Director | Purchase | 100,000 | $100K | Nov 12 | SEC ↗ |
PONS ROBERT MFirst filing | Director | Purchase | 50,000 | $50K | Nov 12 | SEC ↗ |
SHIV SAGIVFirst filing | Director | Purchase | 50,000 | $50K | Nov 12 | SEC ↗ |
Related companies
Marpai, Inc. is in the Healthcare sector.